Envita: The Global Burden of Lyme Disease

Envita Medical Centers is an integrative Center of Excellence for precision oncology and Lyme disease treatment, located in Scottsdale, Arizona. The Envita team has extensive experience treating late-stage and complex cancers, including those resistant to drugs by using proprietary treatments like GTFC™ (Genetically Targeted Fractionated Chemotherapy) and CIPI™ (Chemo Immuno Precision Injections).

GTFC™ is Envita’s low-dose chemotherapy, which is genetically targeted to intensify attack against the cancerous cells, while reducing impact to the surrounding healthy cells. CIPI™ is a minimally invasive procedure for direct deployment of personalized anti-cancer medications at the tumor site. This proprietary interventional radiology procedure is designed to deactivate the tumor, triggering a systemic immune response for identifying cancer cells elsewhere in the body.

Other proprietary treatments including personalized immunotherapies and custom compounded adjuvants are also included in each patient’s personalized protocols. These precision oncology treatments are aimed at targeting the genetic and epigenetic changes responsible for disease growth and spread. This innovative approach helps reduce the severe side effects, typically associated with maximum therapeutic dose untargeted chemotherapy.

Envita implements proprietary next generation sequencing tests, going beyond the standard Elisa and Western Blot tests, for accurate detection and treatment of Lyme disease and its associated coinfections.

Envita

Thursday, February 29, 2024

The Global Burden of Lyme Disease

How Diet and Lifestyle Can Impact Cancer Treatment

Report Abuse

Labels